Full-Time

Senior Project Manager

EVERSANA

EVERSANA

1,001-5,000 employees

Commercial services for pharmaceutical lifecycle management

Compensation Overview

$76k - $110k/yr

Overland Park, KS, USA

Hybrid

Hybrid role; must work in-office once per week (Wednesday) in Overland Park; travel less than 10%.

Category
Business & Strategy (1)
Required Skills
Forecasting
Risk Management
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree or equivalent education plus professional experience required
  • Three to five years of experience in a PMO role
  • Advanced understanding and applications of PMO standards and processes
  • Experience leading the delivery of complex, technology, strategy and creative based projects
  • Ability to develop a creative, strategic or technical heavy project plan
  • Ability to tailor and flex process to provide solutions to proactively facilitate a project
  • Experience leading a wide range of different functional groups and project teams
  • Comprehension of project forecasting and reforecasting throughout lifecycle of project
  • Expert project and program burn analysis and remediation
  • Excellent scope and change management tracking and adherence
  • Comfortable with client-facing communication
  • Strong critical thinking and problem-solving skills, with the ability to anticipate, assess and mitigate risk
  • Ability to build trust, negotiate and influence decision-making with Account, SMEs, Clients, Partner Agencies and third-party vendors
  • Strong sense of ownership and accountability
  • Strong decision-making and implementation, especially when faced with uncertainty
  • Experience working with Project Management Information Systems such as Workfront, Workfront Proof, Smartsheet, MS Project
  • Strong understanding of Microsoft Office Suite, specifically Excel
  • Launch experience a plus
Responsibilities
  • Full lifecycle delivery and management of complex, technical, strategic and creative projects
  • Develops and actively manages project timelines, estimates, risk registers, communication plans, burn reports and change logs with minimal oversight
  • Leads the estimation process and provides project budget and staff plan parameters with minimal supervision
  • Leads the project timeline creation process in close partnership with internal and external stakeholders with minimal supervision
  • Leads project kickoffs and status meetings
  • Creates and/or reviews and distributes meeting recaps; oversees and evolves Project Managers (PM) and Project Coordinators (PC) in their ability to write actionable recaps
  • In partnership with AD and GPD, develops financial forecasts for proactive financial management
  • In partnership with AD, Finance and Account, facilitates monthly billing, analysis and action
  • In partnership with Account Services, AD and GPD, assists with the development of annual and project-based SOWs
  • In partnership with ADs and GPD, provides input to program Gantt Charts
  • In partnership with Account Services, AD and GPD, assists with change order creation and management
  • Actively works with project stakeholders to identify, evaluate, log, communicate and mitigate project-level risks
  • Works closely with PMO leadership to identify and mitigate program-level risks
  • Identifies project staff needs and works with resource managers and PCs to ensure accuracy and updates of resource plans
  • Resolves conflicts, including scope, schedule, resources, budget, quality and communication with minimal oversight
  • Ensures all project artifacts (FRD, BRD, etc.) are properly stored within enterprise systems (Workfront, TFS, etc.)
  • Accountable for application of Intouch delivery processes and PMO standards across their projects
  • Actively mentors and supports training efforts for Project Managers and Project Coordinators
  • Acts as first touchpoint of escalation for Project Managers and PCs
  • Keeps direct manager informed; asks for help when needed; knows when to escalate issues/concerns to leadership; brings solutions
  • Participates in candidate interviews as needed
  • Effectively senses team morale and understands how to address issues
  • modeling inclusive behaviors, and proactively managing bias.
  • All other duties as assigned
Desired Qualifications
  • Pharmaceutical or advertising experience preferred (AOR or DAOR)
  • Launch experience a plus

EVERSANA provides integrated commercial services to pharmaceutical and biotech companies across the product lifecycle. It helps with drug pricing, market access, reimbursement, patient adherence, and product delivery through a service-based model. Its solutions are delivered via a global network of 30+ locations, including consulting, market access strategies, patient services, and field deployment. The goal is to help clients bring products to market, optimize pricing and access, improve adherence, and ensure efficient delivery to improve patient outcomes and commercial performance.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Milwaukee, Wisconsin

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Waltz Health merger creates direct-to-payer model disrupting traditional pharmacy benefits middlemen.
  • AI Agency Platform won 2026 Artificial Intelligence Excellence Award for agentic AI capabilities.
  • Recent executive hires (Guarino, Avram) bring Fortune 100 and agency expertise.

What critics are saying

  • Trinity acquisition of APACME advisory services eliminates regional revenue and market presence.
  • IQVIA's AI platform launch captures 20-30% of biotech launch contracts through scale.
  • Accredo specialty pharmacy expansion locks limited-distribution drugs, slashing rare disease margins 40%.

What makes EVERSANA unique

  • Integrated platform spans entire pharmaceutical lifecycle from launch to patient support.
  • Specialty pharmacy and direct dispensing capabilities enable data collection and patient adherence.
  • Serves 650+ organizations globally with 6,000 professionals across 25+ locations.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at EVERSANA who can refer or advise you

Benefits

Health Insurance

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Conference Attendance Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
PharmaLive
Feb 12th, 2026
EVERSANA names new chief legal officer

EVERSANA names new chief legal officer. EVERSANA has named Monica Avram as Executive Vice President and Chief Legal Officer, a strategic addition as the company scales operations and reinvents commercialization services. As Chief Legal Officer and a member of the Executive Leadership Team, Monica leads the company's global Legal and Compliance function. Her strategic leadership integrates governance, risk, and operational execution to enable innovation, strengthen enterprise performance, and drive long-term value. With more than two decades of experience at top law firms and across global Fortune 100 companies - including UnitedHealth Group and Sanofi - Avram brings deep expertise at the intersection of healthcare, law, and emerging technologies. She has built high-performing, financially disciplined legal teams, advised executive leadership and boards on enterprise strategy, and guided organizations through complex regulatory and operational environments. "As we continue to scale, it's paramount that we have top talent who can understand the complexity of our industry and bring proven track records of success," said Mark Thierer, CEO, EVERSANA. "Throughout her career, Monica has demonstrated exceptional leadership in building best-in-class legal organizations, and we're thrilled to welcome her to EVERSANA." She brings seasoned board and advisory experience across public companies and nonprofit organizations, with deep expertise in governance, oversight, and strategic leadership. Avram holds a BA in Biology from the University of Missouri - Kansas City and a Juris Doctor from Suffolk University Law School.

Business Wire
Nov 3rd, 2025
Trinity Acquires EVERSANA's APACME Services

Trinity has announced the acquisition of EVERSANA's advisory services operation in the Asia-Pacific and Middle East (APACME) regions. This strategic move will transition EVERSANA's APACME advisory services to Trinity, enhancing its global presence in life sciences commercialization solutions.

PR Newswire
Oct 23rd, 2025
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE(R)(lamotrigine) Oral Suspension

OWP Pharmaceuticals selects EVERSANA to support U.S. Launch of SUBVENITE(R)(lamotrigine) Oral Suspension. News provided by. CHICAGO, Oct. 23, 2025 /PRNewswire/ - OWP Pharmaceuticals, a privately held, commercial-stage neuroscience specialty pharmaceutical company, today announced that EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, will provide U.S. commercialization services for the launch of SUBVENITE(R)(lamotrigine) oral suspension, the company's novel treatment for epilepsy and bipolar disorders. SUBVENITE(R), approved by the U.S. Food and Drug Administration on September 16, 2025, is the first and only FDA-approved lamotrigine oral suspension in the U.S. It is designed to help improve access to epilepsy treatments as a flexible, patient-friendly alternative to tablets. Lamotrigine is widely prescribed, but is now available in a ready-to-use liquid version. SUBVENITE(R) Oral Suspension is ideal for patients who have difficulty swallowing tablets, those who require individualized dosing, or prefer liquid medication formulations. To support a successful product launch, EVERSANA is currently activating an array of services, including field deployment, data & analytics, and co-pay services. The SUBVENITE(R) launch support is part of EVERSANA and OWP's broader commercialization partnership announced in January 2022. "Market access challenges continue to be the major hurdle for patients looking for new treatment options," said Gregory Skalicky, President, EVERSANA. "Together with OWP Pharmaceuticals, we're removing barriers and helping patients find new hope." OWP Pharmaceutical's commitment to innovation for patients expands beyond the United States. Since its founding in 2014, the company has developed a unique partnership with the ROW Foundation to support humanitarian efforts for people worldwide with epilepsy. As innovative new solutions like SUBVENITE become available, OWP is committed to ensuring it reaches patients in need, as nearly 80% of people with epilepsy live in underdeveloped countries, and about 75% of them do not have access to a treatment option. "Working with EVERSANA to support commercialization efforts in the U.S. is an important milestone for patients," said Scott Boyer, Founder and President, OWP Pharmaceuticals. "But our vision continues to be much larger, that every epilepsy patient globally one day might have access through OWP Pharma and ROW Foundation, the Pharmaceutical Social Enterprise(R). To learn more about OWP Pharmaceuticals, visit www.owppharma.com. About EVERSANA EVERSANA(R) is a leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X. About OWP Pharmaceuticals OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and commercializing novel oral liquid formulations. Based in Lisle, IL, OWP is committed to advancing therapies in neurology and psychiatry, with a mission to bring meaningful innovations to patients. Through its partnership with the ROW Foundation, OWP also supports global initiatives to improve epilepsy care and education in underserved communities worldwide. For EVERSANA Matt Braun Vice President, Corporate Communications [email protected] SOURCE EVERSANA; OWP Pharmaceuticals

Arkansas Democrat-Gazette
Aug 27th, 2025
Eversana acquires Waltz Health

Eversana, a company that helps drugmakers sell their medicines, has acquired a smaller firm called Waltz Health that helps employers and health insurance companies purchase cheaper drugs, in a bid to build an alternative to traditional pharmacy benefits middlemen in the U.S.

PharmaLive
Aug 26th, 2025
EVERSANA Merges with Waltz Health

EVERSANA merges with Waltz Health.